Evidence map›Paper›PMID 35938726›Full record

ArticlemBio2022

Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.

Man Chun Chiu, Cun Li, Xiaojuan Liu, Wenjun Song, Zhixin Wan, Yifei Yu, Jingjing Huang, Ding Xiao, Hin Chu, Jian-Piao Cai and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. [Establishment of an Epstein-Barr virus infection model using human nasal organoids].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Olfactory models as a platform for neuroscience research.Frontiers in cellular neuroscience · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Man Chun Chiu *Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
Cun Li *Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
Xiaojuan Liu *Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
Wenjun Song *State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhixin WanDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
Yifei YuDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
Jingjing HuangDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
Ding XiaoDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
Hin ChuDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
Jian-Piao CaiDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
Kelvin Kai-Wang ToDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.ORCID 0000-0002-1921-5824
Kwok Yung YuenDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.ORCID 0000-0001-8700-4570
Jie ZhouDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Pokfulam, Hong Kong, China.
University of Hong Kong · HKHong Kong Science and Technology Parks Corporation · HKFirst Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human upper respiratory tract, specifically the nasopharyngeal epithelium, is the entry portal and primary infection site of respiratory viruses. Productive infection of SARS-CoV-2 in the nasal epithelium constitutes the cellular basis of viral pathogenesis and transmissibility. Yet a robust and well-characterized

Indexed as

COVID-19Nasal MucosaOrganoidsSARS-CoV-2HumansTissue Culture Techniquesairway organoidsciliary damagenasal organoidsSARS-CoV-2tight junction

Identifiers

PMID35938726
PMCPMC9426414
OpenAlexW4290649233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.